Antithrombotic Therapy in a Prospective Trial of a Pediatric Ventricular Assist Device

被引:44
作者
Steiner, Marie E. [1 ,2 ]
Bomgaars, Lisa R. [3 ]
Masicotte, M. Patricia [4 ]
机构
[1] Univ Minnesota, Dept Pediat, Div Hematol, MMC 484,420 Delaware St, Minneapolis, MN 55455 USA
[2] Univ Minnesota, Dept Pediat, Div Crit Care, MMC 484,420 Delaware St, Minneapolis, MN 55455 USA
[3] Texas Childrens Hosp, Baylor Coll Med, Houston, TX 77030 USA
[4] Stollery Childrens Hosp, Dept Pediat, Edmonton, AB, Canada
关键词
anticoagulation; ventricular assist device; pediatric; hemostasis; CONTINUOUS-FLOW DEVICE; HEART-TRANSPLANTATION; CHILDREN; MULTICENTER; OUTCOMES;
D O I
10.1097/MAT.0000000000000434
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Efficacious ventricular assist device (VAD) support in pediatric patients depends on successful antithrombotic management. The experience with antithrombotic management for the EXCOR Pediatric VAD Investigational Device Exemption (IDE) study is described. All 68 children in North America enrolled in the IDE study from May 9, 2007 to December 10, 2010 are included. The Edmonton Anticoagulation and Platelet Inhibition Protocol was provided for management guidance. Monitoring parameters, drug dosing, targeted serious adverse events, and pump changes were reviewed. Major bleeding occurred in 43% of all subjects with most events occurring within 14 days of implantation. Bleeding events were probably/definitely related in 24% to antithrombotic management. Neurologic events occurred in 28% of subjects and were probably/definitely related in 9% to antithrombotic therapy intensity. Most neurologic events occurred between 4 and 30 days postimplantation and sporadically thereafter. Pump change occurred in 56% of subjects. Use of an antithrombotic protocol for enrolled subjects was possible in this multicenter study. Incidence of significant bleeding and thromboembolic events was acceptable when balanced against life-saving benefits of VADs. Further studies are needed to optimize the antithrombotic management of this patient population.
引用
收藏
页码:719 / 727
页数:9
相关论文
共 21 条
[1]   Berlin Heart EXCOR Pediatric Ventricular Assist Device for Bridge to Heart Transplantation in US Children [J].
Almond, Christopher S. ;
Morales, David L. ;
Blackstone, Eugene H. ;
Turrentine, Mark W. ;
Imamura, Michiaki ;
Massicotte, M. Patricia ;
Jordan, Lori C. ;
Devaney, Eric J. ;
Ravishankar, Chitra ;
Kanter, Kirk R. ;
Holman, William ;
Kroslowitz, Robert ;
Tjossem, Christine ;
Thuita, Lucy ;
Cohen, Gordon A. ;
Buchholz, Holger ;
St Louis, James D. ;
Khanh Nguyen ;
Niebler, Robert A. ;
Walters, Henry L., III ;
Reemtsen, Brian ;
Wearden, Peter D. ;
Reinhartz, Olaf ;
Guleserian, Kristine J. ;
Mitchell, Max B. ;
Bleiweis, Mark S. ;
Canter, Charles E. ;
Humpl, Tilman .
CIRCULATION, 2013, 127 (16) :1702-+
[2]   Berlin Heart EXCOR Pediatric ventricular assist device Investigational Device Exemption study: Study design and rationale [J].
Almond, Christopher S. ;
Buchholz, Holger ;
Massicotte, Patricia ;
Ichord, Rebecca ;
Rosenthal, David N. ;
Uzark, Karen ;
Jaquiss, Robert D. B. ;
Kroslowitz, Robert ;
Kepler, Mary Beth ;
Lobbestael, Aaron ;
Bellinger, David ;
Blume, Elizabeth D. ;
Fraser, Charles D., Jr. ;
Bartlett, Robert H. ;
Thiagarajan, Ravi ;
Jenkins, Kathy .
AMERICAN HEART JOURNAL, 2011, 162 (03) :425-U41
[3]  
[Anonymous], QUALITY LAB HEMOSTAS
[4]  
[Anonymous], INTERMACS MANUAL OPE
[5]   Evaluation of enoxaparin dosing requirements in infants and children Better dosing to achieve therapeutic levels [J].
Bauman, Mary E. ;
Belletrutti, Mark J. ;
Bajzar, Laszlo ;
Black, Karina L. ;
Kuhle, Stefan ;
Bauman, Michelle L. ;
Massicotte, M. Patricia .
THROMBOSIS AND HAEMOSTASIS, 2009, 101 (01) :86-92
[6]   Outcomes of children bridged to heart transplantation with ventricular assist devices - A multi-institutional study [J].
Blume, ED ;
Naftel, DC ;
Bastardi, HJ ;
Duncan, BW ;
Kirklin, JK ;
Webber, SA .
CIRCULATION, 2006, 113 (19) :2313-2319
[7]   Steroid Therapy Attenuates Acute Phase Reactant Response Among Children on Ventricular Assist Device Support [J].
Byrnes, Jonathan W. ;
Bhutta, Adnan T. ;
Rettiganti, Mallikarjuna Rao ;
Gomez, Alberto ;
Garcia, Xiomara ;
Dyamenahalli, Umesh ;
Johnson, Charles ;
Jaquiss, Robert D. B. ;
Imamura, Michiaki ;
Prodhan, Parthak .
ANNALS OF THORACIC SURGERY, 2015, 99 (04) :1392-1398
[8]   OPTN/SRTR 2013 Annual Data Report: Heart [J].
Colvin-Adams, M. ;
Smith, J. M. ;
Heubner, B. M. ;
Skeans, M. A. ;
Edwards, L. B. ;
Waller, C. D. ;
Callahan, E. R. ;
Snyder, J. J. ;
Israni, A. K. ;
Kasiske, B. L. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15 :1-28
[9]   Prospective Trial of a Pediatric Ventricular Assist Device [J].
Fraser, Charles D., Jr. ;
Jaquiss, Robert D. B. ;
Rosenthal, David N. ;
Humpl, Tilman ;
Canter, Charles E. ;
Blackstone, Eugene H. ;
Naftel, David C. ;
Ichord, Rebecca N. ;
Bomgaars, Lisa ;
Tweddell, James S. ;
Massicotte, M. Patricia ;
Turrentine, Mark W. ;
Cohen, Gordon A. ;
Devaney, Eric J. ;
Pearce, F. Bennett ;
Carberry, Kathleen E. ;
Kroslowitz, Robert ;
Almond, Christopher S. .
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (06) :532-541
[10]   Change in Heparin Potency and Effects on the Activated Clotting Time in Children Undergoing Cardiopulmonary Bypass [J].
Guzzetta, Nina A. ;
Amin, Sapan J. ;
Tosone, Alexandra K. ;
Miller, Bruce E. .
ANESTHESIA AND ANALGESIA, 2012, 115 (04) :921-924